Innovation Council released a statement to the WIPO Standing Committee on the Law of Patents presenting recent research on tech transfer. We highlighted the work we did with two Innovation Council members, Merck Life Science and Biovac.
With Merck Life Science, Innovation Council published a paper called Making Biologics, which found four pathways for building bio-manufacturing and innovative capacity that required collaboration, tech transfer, and IP protection. One uncovered strategy involved building vaccine production capacity through a process of “backwards integration,” that involved working with tech transfer partners to gain expertise to ultimately help perform R&D. Biovac demonstrated an example of a backwards integration success story through their work.
See here for our full statement.